FRANCESCO DEMAYO to Islets of Langerhans
This is a "connection" page, showing publications FRANCESCO DEMAYO has written about Islets of Langerhans.
Connection Strength
0.381
-
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
Score: 0.091
-
Alterations in glucose homeostasis in SSTR1 gene-ablated mice. Mol Cell Endocrinol. 2006 Mar 09; 247(1-2):82-90.
Score: 0.058
-
The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice. J Surg Res. 2005 Nov; 129(1):64-72.
Score: 0.056
-
SSTR5 ablation in islet results in alterations in glucose homeostasis in mice. FEBS Lett. 2005 Jun 06; 579(14):3107-14.
Score: 0.055
-
Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice. J Surg Res. 1999 Jun 15; 84(2):199-203.
Score: 0.037
-
A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system. Biochem Biophys Res Commun. 1998 Dec 09; 253(1):65-9.
Score: 0.035
-
Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas. World J Surg. 2009 Apr; 33(4):630-7.
Score: 0.018
-
Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice. Surgery. 2004 Sep; 136(3):585-92.
Score: 0.013
-
Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion. J Biol Chem. 2000 Mar 31; 275(13):9270-7.
Score: 0.010
-
Tissue-specific and developmental regulation of the rat insulin II gene enhancer, RIPE3, in transgenic mice. J Biol Chem. 1997 Feb 07; 272(6):3567-72.
Score: 0.008